Moderna (MRNA) ROE US GAAP (year values) |
|||||||||
2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
ROE, % | ? | -29.2% | 86.3% | 43.7% | 43.7% | -34.0% | -50.1% | ||
Changes by years, y/y, % | +15pp | +115pp | -43pp | 0pp | -78pp | +6.2% |
Moderna. ROE, %
Moderna. ROE, changes, pp
Moderna (MRNA) ROE US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
ROE, % | ? | -25.8% | -25.8% | -34.0% | -46.6% | -50.1% | -50.1% | |
Changes by years, y/y, % | -91pp | -91pp | -78pp | -72pp | -57pp | |||
Changes by quarters, q/q, % | -33pp | 0pp | -8pp | -13pp | -4pp |